Combined therapy of lapatinib and capecitabine effective against local recurrence of breast cancer

Tadahiro Nozoe, Emiko Nozoe, Tomohiro Iguchi, Shuhei Ito, Takefumi Ohga, Tetsuya Koga, Takahiro Ezaki

Research output: Contribution to journalArticle

Abstract

A 67-year-old woman after mastectomy was afflicted with local recurrence of left breast cancer during adjuvant trastuzumab therapy. Oral administration of lapatinib and capecitabine served to distinguish the recurrent tumor and also reduce the patient's distressing symptoms. This combined anti-cancer therapy may be available for patients with breast cancer for whom trastuzumab therapy was not adequately effective.

Original languageEnglish
Pages (from-to)907-908
Number of pages2
JournalJapanese Journal of Cancer and Chemotherapy
Volume40
Issue number7
Publication statusPublished - Jan 1 2013

Fingerprint

Breast Neoplasms
Recurrence
Mastectomy
Oral Administration
Neoplasms
Therapeutics
Capecitabine
lapatinib
Trastuzumab

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Nozoe, T., Nozoe, E., Iguchi, T., Ito, S., Ohga, T., Koga, T., & Ezaki, T. (2013). Combined therapy of lapatinib and capecitabine effective against local recurrence of breast cancer. Japanese Journal of Cancer and Chemotherapy, 40(7), 907-908.

Combined therapy of lapatinib and capecitabine effective against local recurrence of breast cancer. / Nozoe, Tadahiro; Nozoe, Emiko; Iguchi, Tomohiro; Ito, Shuhei; Ohga, Takefumi; Koga, Tetsuya; Ezaki, Takahiro.

In: Japanese Journal of Cancer and Chemotherapy, Vol. 40, No. 7, 01.01.2013, p. 907-908.

Research output: Contribution to journalArticle

Nozoe, T, Nozoe, E, Iguchi, T, Ito, S, Ohga, T, Koga, T & Ezaki, T 2013, 'Combined therapy of lapatinib and capecitabine effective against local recurrence of breast cancer', Japanese Journal of Cancer and Chemotherapy, vol. 40, no. 7, pp. 907-908.
Nozoe, Tadahiro ; Nozoe, Emiko ; Iguchi, Tomohiro ; Ito, Shuhei ; Ohga, Takefumi ; Koga, Tetsuya ; Ezaki, Takahiro. / Combined therapy of lapatinib and capecitabine effective against local recurrence of breast cancer. In: Japanese Journal of Cancer and Chemotherapy. 2013 ; Vol. 40, No. 7. pp. 907-908.
@article{bc764c7974f241479a18d13d9817bf56,
title = "Combined therapy of lapatinib and capecitabine effective against local recurrence of breast cancer",
abstract = "A 67-year-old woman after mastectomy was afflicted with local recurrence of left breast cancer during adjuvant trastuzumab therapy. Oral administration of lapatinib and capecitabine served to distinguish the recurrent tumor and also reduce the patient's distressing symptoms. This combined anti-cancer therapy may be available for patients with breast cancer for whom trastuzumab therapy was not adequately effective.",
author = "Tadahiro Nozoe and Emiko Nozoe and Tomohiro Iguchi and Shuhei Ito and Takefumi Ohga and Tetsuya Koga and Takahiro Ezaki",
year = "2013",
month = "1",
day = "1",
language = "English",
volume = "40",
pages = "907--908",
journal = "Japanese Journal of Cancer and Chemotherapy",
issn = "0385-0684",
publisher = "Japanese Journal of Cancer and Chemotherapy Publishers Inc.",
number = "7",

}

TY - JOUR

T1 - Combined therapy of lapatinib and capecitabine effective against local recurrence of breast cancer

AU - Nozoe, Tadahiro

AU - Nozoe, Emiko

AU - Iguchi, Tomohiro

AU - Ito, Shuhei

AU - Ohga, Takefumi

AU - Koga, Tetsuya

AU - Ezaki, Takahiro

PY - 2013/1/1

Y1 - 2013/1/1

N2 - A 67-year-old woman after mastectomy was afflicted with local recurrence of left breast cancer during adjuvant trastuzumab therapy. Oral administration of lapatinib and capecitabine served to distinguish the recurrent tumor and also reduce the patient's distressing symptoms. This combined anti-cancer therapy may be available for patients with breast cancer for whom trastuzumab therapy was not adequately effective.

AB - A 67-year-old woman after mastectomy was afflicted with local recurrence of left breast cancer during adjuvant trastuzumab therapy. Oral administration of lapatinib and capecitabine served to distinguish the recurrent tumor and also reduce the patient's distressing symptoms. This combined anti-cancer therapy may be available for patients with breast cancer for whom trastuzumab therapy was not adequately effective.

UR - http://www.scopus.com/inward/record.url?scp=84884483019&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884483019&partnerID=8YFLogxK

M3 - Article

C2 - 23863733

AN - SCOPUS:84884483019

VL - 40

SP - 907

EP - 908

JO - Japanese Journal of Cancer and Chemotherapy

JF - Japanese Journal of Cancer and Chemotherapy

SN - 0385-0684

IS - 7

ER -